Jackson Blasts Ill Health Rumours

23 Dec 2008
By Ahlanlive.com

Publicist says he's healthy and planning a world tour

MICHAEL JACKSON has announced he is preparing for a comeback world tour, blasting recent reports he is suffering from a deadly lung condition.

Author Ian Halperin sparked rumours the star is seriously ill after telling Britain's Sunday Express this week Jackson is suffering from a condition known as Alpha-1 antitrypsin deficiency (A1AD), a potentially fatal genetic illness.

Halperin, who is writing a new book about Jackson's life, also alleged the Thriller hitmaker is losing the vision in his left eye and even needs a lung transplant after developing emphysema, which can be caused by A1AD.

But a spokesperson for the star is adamant Jackson is perfectly healthy - and is even preparing to step back into the spotlight for a world tour.

His publicist says: "Concerning this author's allegations, we would hope in the future that legitimate media will not continue to be exploited by such an obvious attempt to promote this unauthorised 'biography.'

"The writer's wild allegations concerning Mr Jackson's health are a total fabrication. Mr Jackson is in fine health, and finalising negotiations with a major entertainment company and television network for both a world tour and a series of specials and appearances."

Meanwhile, Jackson has taken out a $100,000-a-month lease on a new mansion - just one month after relinquishing his debt-steeped Neverland Ranch to an investment firm.

He has signed a deal for a $37 million chateau in Holmby Hills, California, which has seven bedrooms, 13 bathrooms and a home cinema.

The three-storey property also boasts a curved staircase, a pool and 12 fireplaces.

Just last month, Jackson handed over the title to his Neverland Ranch in California to a private equity group Colony Capital, which agreed to take over the singer's $24.5 million debt on the property.

The star was forced to sell the famed Ranch after its sweeping grounds drained his finances - it cost him $25 million to buy and $3 million a year to run.